Progenesis is the first company in the US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). We offer embryo screening for many common diseases including cystic fibrosis, Fragile X syndrome, sickle cell disease, and Tay-Sachs disease. We have introduced the most accurate test in the IVF field for 24-chromosome aneuploidy screening and single gene disorder. 

At Progenesis, we believe in innovation. Our expert scientists are constantly working to improve our products through research and development. Our goal is to provide our patients with the latest, most advanced technology and information to equip them with the best tools to build healthy families.

For more information, please visit www.progenesis.com.
#Progenesis #Biotechnology #GeneticTesting #Innovation #IVF #Infertility #Diagnosis 

Health Diagnostics

Health Care

Biotechnology

Progenesis

Progenesis' headquarters in La Jolla, CA, United States

People (10)

Jobs (0)

Other offices